The Hendra virus vaccine was registered in 2015. Details about the registered product, including the approved label are available from the APVMA public chemical registration information system (PUBCRIS). The product number is 68996. The approved label provides details on the dosage, administration and precautions for the Hendra virus vaccine.
Equivac HeV Hendra virus vaccine contains soluble forms of G glycoprotein (sG) of Hendra virus, adjuvented with an immunostimulating complex. It does not contain any live or inactivated virus.
Directions for use are detailed in the approved product label for the Equivac HeV Hendra virus vaccine.
A summary of the dosing schedule is provided below.
|Vaccination Type||Timing Interval|
|First Dose||Day 1|
|Second Dose||Day 21 – 42|
|Third Dose||6 months after the second dose|
|Annual Booster||12 month (annual) boosters after the third dose|
Information included in this table was accurate on 13 December 2018. Refer to the approved product label for up-to-date dosing information.